A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Hyperlipidemia
Interventions
DRUG

HRS-1301 Tablets

HRS-1301 tablets.

DRUG

Rosuvastatin Calcium Tablets

Rosuvastatin calcium tablets.

Trial Locations (1)

215004

The Second Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY